M. G. Gimeno

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses.

N. Sonenberg, W. Miller, Jie Su, 2021, The Journal of clinical investigation.

The MNK1/2-eIF4E axis drives melanoma plasticity, progression, and resistance to immunotherapy

N. Sonenberg, W. Miller, Jie Su, 2020, bioRxiv.